SERIAL MEASUREMENT OF CA 125 IN PATIENTS WITH PRIMARY-CARCINOMA OF THE FALLOPIAN-TUBE

被引:27
|
作者
TOKUNAGA, T [1 ]
MIYAZAKI, K [1 ]
MATSUYAMA, S [1 ]
OKAMURA, H [1 ]
机构
[1] KUMAMOTO UNIV,SCH MED,KUMAMOTO 860,JAPAN
关键词
D O I
10.1016/0090-8258(90)90137-A
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Serial assay of serum CA 125 was carried out in five patients with advanced primary carcinoma of the fallopian tube. Pretreatmental levels of these patients were elevated, ranging from 145 to 535 U/ml (305 ± 140.1, mean ± SD). All patients showed rapid decreases in response to treatment; however, reelevations were noted in two patients concomitant with recurrence. In the remaining three patients, who are alive with no evidence of recurrence at 52,29, and 21 months, serum CA 125 levels remained below 5 U/ml after remission. These results suggest that CA 125 is useful in monitoring patients with primary carcinoma of the fallopian tube. © 1990.
引用
下载
收藏
页码:335 / 337
页数:3
相关论文
共 50 条
  • [41] THE MANAGEMENT OF PRIMARY FALLOPIAN-TUBE CARCINOMA
    GURNEY, H
    MURPHY, D
    CROWTHER, D
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (09): : 822 - 826
  • [42] PRIMARY ADENOSQUAMOUS CARCINOMA OF THE FALLOPIAN-TUBE
    IMM, FC
    SOUTHERN MEDICAL JOURNAL, 1980, 73 (05) : 678 - 680
  • [43] LEVELS OF CA 125 IN PATIENTS WITH RECURRENT CARCINOMA OF THE FALLOPIAN-TUBE - 2 CASE-HISTORIES
    LOOTSMAMIKLOSOVA, E
    AALDERS, JG
    WILLEMSE, PHB
    DEBRUIJN, HWA
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 24 (03): : 231 - 235
  • [44] PREOPERATIVE DIAGNOSIS OF PRIMARY FALLOPIAN-TUBE CARCINOMA BY TRANSVAGINAL ULTRASOUND, CYTOLOGICAL FINDING AND CA-125
    PODOBNIK, M
    SINGER, Z
    CIGLAR, S
    BULIC, M
    ULTRASOUND IN MEDICINE AND BIOLOGY, 1993, 19 (07): : 587 - 591
  • [45] PREOPERATIVE DIAGNOSIS OF FALLOPIAN-TUBE CARCINOMA BY TRANSVAGINAL SONOGRAPHY AND CA-125
    KOL, S
    GAL, D
    FRIEDMAN, M
    PALDI, E
    GYNECOLOGIC ONCOLOGY, 1990, 37 (01) : 129 - 131
  • [46] PROGNOSTIC FACTORS IN PRIMARY FALLOPIAN-TUBE CARCINOMA
    ROSEN, AC
    REINER, A
    KLEIN, M
    LAHOUSEN, M
    GRAF, AH
    VAVRA, N
    AUERBACH, L
    VORBECK, F
    ROSEN, HR
    ALPI, G
    ALTMUTTER, C
    BARTUSSEK, G
    BAYR, M
    BECKER, H
    BIBUS, B
    BICHLER, A
    CZERWENKA, K
    DINGES, HP
    FEIGL, W
    FINK, A
    FRIEDRICH, F
    FUITH, F
    GEORGIADES, E
    GOGL, H
    GRUNBERGER, W
    HACKL, A
    KAHN, K
    KARASEGH, S
    KERAK, A
    KOSAK, D
    KRAHULETZ, H
    KRATOCHWIL, A
    KREMSER, J
    LEODOLTER, L
    MACHACEK, E
    MAYER, H
    MEDL, M
    NAUDE, S
    NEMEC, H
    PAVELKA, R
    PFLANZL, W
    SALZER, H
    SCHENK, E
    SCHROCK, A
    SEJDL, A
    STIGLBAUER, M
    STIGLBAUER, W
    SZALAY, S
    TASCHNER, R
    TSCHARF, J
    GYNECOLOGIC ONCOLOGY, 1994, 53 (03) : 307 - 313
  • [47] DELAYED RECURRENCES IN PRIMARY FALLOPIAN-TUBE CARCINOMA
    KHANDEKAR, JD
    BECK, HH
    SOUTHERN MEDICAL JOURNAL, 1993, 86 (11) : 1314 - 1315
  • [48] FALLOPIAN-TUBE CARCINOMA
    IBRAHIM, Z
    DAW, EG
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 10 (02) : 158 - 160
  • [49] IMMUNOHISTOCHEMICAL STAINING FOR CA-125 IN FALLOPIAN-TUBE CARCINOMAS
    PULS, LE
    DAVEY, DD
    DEPRIEST, PD
    GALLION, HH
    VANNAGELL, JR
    HUNTER, JE
    PAVLIK, EJ
    GYNECOLOGIC ONCOLOGY, 1993, 48 (03) : 360 - 363
  • [50] FALLOPIAN-TUBE CARCINOMA
    EDDY, GL
    COPELAND, LJ
    GERSHENSON, DM
    ATKINSON, EN
    WHARTON, JT
    RUTLEDGE, FN
    OBSTETRICS AND GYNECOLOGY, 1984, 64 (04): : 546 - 552